drugset / Trial / NCT07531108
Effects of Empagliflozin-Metformin, Sitagliptin-Metformin, and Metformin on Adipokines in Type 2 Diabetes
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study compared the impacts of empagliflozin-metformin, sitagliptin-metformin, and metformin monotherapy in treatment-naive overweight or obese adults with newly diagnosed type 2 diabetes mellitus in Erbil, Iraq. The study monitored participants for 12 weeks. It determined changes in serum omentin-1, resistin, glycemic markers, and anthropometric measures.
Timeline
- Start
- 2024-11-15
- Primary completion
- 2025-11-27
- Completion
- 2025-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Empagliflozin | Small molecule | — | Oral |
| Comparator | Metformin | Small molecule | — | Oral |
| Comparator | Sitagliptin | Small molecule | — | Oral |